• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB

MESOBLAST LIMITED

1.44% ! $2.05
Market Cap $2.695B  !
Healthcare Biotechnology
Add to My Watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MSB
Mesoblast kicks off Ryoncil sales in US but shareholders eager for revenue 		27/03/25 0 1
27/03/25 Last post  Comments Created with Sketch.  0  Views Created with Sketch.  1 
MSB
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
2
24/04/18 107 20K
24/04/18 Last post  Paulc8166 Comments Created with Sketch.  107  Views Created with Sketch.  20K 
MSB
MSB trading
11 12 13
23/04/18 776 180K
TRENDING NEWS

COULD THIS BE THE NEXT BIG CRITICAL MINERALS COMPANY?

See the stock and why timing matters now right-arrow Created with Sketch.
NEWS
08 Jul 2026
23/04/18 Last post  Fruitbat2 Comments Created with Sketch.  776  Views Created with Sketch.  180K 
MSB
Scientists use stem cells to grow a BEATING human heart muscle for the first time ever Read more: h 		23/04/18 0 153
23/04/18 Last post  Amonda Comments Created with Sketch.  0  Views Created with Sketch.  153 
MSB
Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA fundin 		21/04/18 0 357
21/04/18 Last post  Amonda Comments Created with Sketch.  0  Views Created with Sketch.  357 
MSB
Wired News - Mesoblast Announced Updated Data from Phase-3 and Phase-2b Clinical Trials of MPC-150-I 		21/04/18 0 377
21/04/18 Last post  Amonda Comments Created with Sketch.  0  Views Created with Sketch.  377 
MSB
meso 		20/04/18 1 573
20/04/18 Last post  LawyerTrader Comments Created with Sketch.  1  Views Created with Sketch.  573 
MSB
Stem Cells Used to Grow a Beating Human Heart Muscle in 4 weeks 		19/04/18 0 209
19/04/18 Last post  col69 Comments Created with Sketch.  0  Views Created with Sketch.  209 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Syntara shows encouraging first signals it can impact the path to Parkinson's
right-arrow Created with Sketch.
SNT Syntara shows encouraging first signals it can impact the path to Parkinson's
right-arrow Created with Sketch.
NEWS Bright light: Diablo receives final approvals for maiden Star Range diamond drilling
right-arrow Created with Sketch.
NEWS What the wealthy know about market volatility most people will never be told – and how you can use it to your advantange
right-arrow Created with Sketch.
NEWS Australia's resources and energy exports remain strong, despite Middle East crisis
right-arrow Created with Sketch.
NEWS Gold has fallen 30% since its high this year – time to buy?
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$2.05 		Change
-0.030(1.44%) 		Mkt cap ! $2.695B
Open High Low Volume
$2.07 $2.08 $2.02 1.519M

Buyers (Bids)

Vol. Price($)
78962 $2.03
 

Sellers (Offers)

Price($) Vol.
$2.06 18085
Last trade - 16.29pm 07/07/2026 (20 minute delay) ?
MSB (ASX) Chart

Top Stories

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

Carrara Capital CIO David Sokulsky on why he's bullish on AI but cautious on valuations, Nvidia, SK Hynix, and his top trading advice.
Australia's resources and energy exports remain strong, despite Middle East crisis The AI investment boom is helping to generate demand for Australia’s resources and energy commodities according to new federal data.
Diablo: Horn Silver acquisition approved, maiden Star Range drilling set to commence Diablo Resources CEO Lyle Thorne joins HotCopper to discuss acquisition of the historic Horn Silver in Utah, as well as final drill permits.
LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson talk about all the inflation data that’s come out in Australia this week and whether the Reserve Bank will go for another hike in August, as well as the H5 bird flu scare in WA @ and what t...
Syntara shows encouraging first signals it can impact the path to Parkinson's Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence that the company’s novel anti-inflammatory therapy may be targeting a key biological process linked to the development of Parkinson’...

Featured News

NEWS Talga Group and Mitsubishi execute anode supply LOI
right-arrow Created with Sketch.
NEWS Australia's resources and energy exports remain strong, despite Middle East crisis
right-arrow Created with Sketch.
NEWS Syntara shows encouraging first signals it can impact the path to Parkinson's
right-arrow Created with Sketch.
NEWS What the wealthy know about market volatility most people will never be told – and how you can use it to your advantange
right-arrow Created with Sketch.
SNT Syntara shows encouraging first signals it can impact the path to Parkinson's
right-arrow Created with Sketch.
NEWS Bright light: Diablo receives final approvals for maiden Star Range diamond drilling
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.